Dr. David Gastfriend

Dr. David Gastfriend

Board Member

NPAMC Board Member Dr. David Gastfriend is Vice President for Scientific Communications at Alkermes, Inc. where he is involved in research, education, and scientific publication on behalf of the company’s efforts in the field of addiction treatment. For over two decades, he served on the faculty of Harvard Medical School − most recently as Associate Professor of Psychiatry − as well as the Director of the Addiction Research Program at Massachusetts General Hospital, where he founded the Fellowship in Addiction Psychiatry and provided clinical care to substance abuse patients.

One of the few physicians in the country to be certified both in Addiction Medicine and Addiction Psychiatry, David has conducted studies on both pharmacologic and behavioral treatments of alcohol and drug use disorders. He initiated the first multi-site study to validate and refine the Patient Placement Criteria published by the American Society of Addiction Medicine, for which he was funded for seven years by the National Institute on Drug Abuse (NIDA). In 2001, he was the recipient of a five-year Mid-Career Investigator Award for Patient-Oriented Research from NIDA, and in 2002 he was a nominee for the Robert Wood Johnson Foundation Award, “Innovators Combating Substance Abuse.” In 2007, he was named a “Champion in Health Care – Innovator Award” by the Boston Business Journal for his work with Vivitrol®.

In his esteemed career, David has been an author or editor of over 125 scientific publications, with editorial board memberships, including The Journal of Substance Abuse Treatment, The Journal of Addictive Diseases, and The Journal of Computers in Human Services. He is co-editor of the leading book on treatment matching in the field, The ASAM Patient Placement Criteria for Substance-Related Disorders and editor of Addiction Treatment Matching. David has also served on the Board of Directors of the American Society of Addiction Medicine (ASAM), chairing its Treatment Outcome Research Committee, and also served on the Board of Directors of the International Society of Addiction Medicine (ISAM).

David received his B.A. at Haverford College in Philadelphia, and his M.D. from Jefferson Medical College in Philadelphia.